Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Changes in Stockholders' Equity (Deficit)

v3.20.1
Condensed Consolidated Statements of Changes in Stockholders' Equity (Deficit) - USD ($)
Treasury Stock [Member]
Common stock
Additional Paid-In Capital [Member]
Accumulated Deficit [Member]
Total
Balance, beginning at Sep. 30, 2018   $ 573 $ (517) $ (41,952) $ (41,896)
Balance, beginning, shares at Sep. 30, 2018   5,727,090      
Net loss       (1,488,488) (1,488,488)
Balance, ending at Dec. 31, 2018 $ (140) $ 573 1,137,512 (1,530,440) (392,495)
Balance, ending, shares at Dec. 31, 2018 (1,401,202) 5,727,090      
Stock-based compensation expense     293,303   293,303
Repurchase of common stock $ (140)   126   (14)
Repurchase of common stock (in shares) (1,401,202)        
Common stock for research and development expense- license acquired - CMU     844,600   844,600
Balance, beginning at Sep. 30, 2019 $ 0 $ 1,708 37,027,875 (27,000,199) $ 10,029,384
Balance, beginning, shares at Sep. 30, 2019   17,077,873     2,829,248
Net loss 0 $ 0 0 (4,505,550) $ (4,505,550)
Balance, ending at Dec. 31, 2019 0 $ 1,708 38,532,101 (31,505,749) $ 7,028,060
Balance, ending, shares at Dec. 31, 2019   17,077,873     2,829,248
Stock-based compensation expense $ 0 $ 0 $ 1,504,226 $ 0 $ 1,504,226